u/niels_roos

if the maths gives you a fraction of a unit, change the concentration

Which country, and which country did it ship from?

the trials were not designed to answer most of the questions asked here

a 503B has to register and report, so there is a paper trail to ask for

Does the effect persist with continued dosing or does tolerance develop?

If your calculation produces a fraction of a unit, the concentration is wrong for your dose. Change the water volume until the numbers land on whole units.

Which receptor arm are you attributing that to?

Yes — hair shedding tracks the rate of loss and it is temporary. That reassurance is worth repeating.

Small fix — a U-100 syringe is 100 units per mL. If yours is marked differently it is not U-100 and the whole calculation changes.

Aim the stream down the wall of the vial rather than into the cake. Reconstitution is a solubility problem, not a mixing problem, and mechanical shear does nothing helpful.

the trials were not designed to answer most of the questions asked here

Push back: "compounded is fine because a pharmacy made it" skips every question this board exists to ask.

dead space in the needle hub is real and it is small

What is written on the vial right now?

cycle timing changes how the same week feels

That trial did not enrol the population you are asking about, so it cannot answer this.

Correction: that is a request for information, not a seizure notice. Different document, different process, different deadline.

Have you asked the supplier what they declare?

the answer for New Zealand does not apply anywhere else

Disagree that the pace matters as much as you think. Durable is better than fast and nobody posts about durable.

I would not read the price difference as a quality signal.

Agreed — and the follow-up question is what the beyond-use date is based on.

Where in the cycle does this fall, if you are tracking it?

Rate of change is not a virtue. Slower trajectories are as durable as fast ones and are considerably better represented on this board than the front page suggests.

Yes, and the dead-space point is worth repeating: it is small, it is real, and it is the same for every draw.

Agreed — the incretin effect is the load-bearing concept and everything downstream reads differently once you have it.

incretin effect first, then everything else in this board makes sense

do not assume the concentration matches the branded product

Insulin resistance is a common feature in PCOS, which is why the metabolic conversation overlaps so heavily with this board. A diagnosis and a finding are still different things and the distinction matters for what the evidence says.

Disagreeing with this specific inference — that is a preclinical result being read as human pharmacology.

Agreed — and it is why the central and peripheral stories are complementary rather than rival.

The arithmetic in full: concentration is mass over volume, so 20mg into 2mL gives 10mg/mL. A U-100 syringe is graduated at 100 units per millilitre, so 1mg is 1 divided by 10 millilitres, which is 10 units.

Same. I got this wrong once, caught it because the units looked absurd, and have written on every vial since.

A hold, a request for information and a seizure are distinct administrative events. Each has its own process and deadlines, and the notice itself states which one you have.

Cosigning on paperwork. The boring documents are the ones that matter when a process starts.

Not convinced comparison helps here. The people posting the fastest results are the tail of a distribution, not the middle.

Asked the supplier what documentation travels with the shipment and got a straight answer. That was reassuring in itself.

if a clinic will not name the facility, that is your answer

Who is the prescriber, and are they the same organisation as the pharmacy?

the API source is the question nobody asks and everybody should